Search research articles
Contact Us
Filters
Showing results (151-160 of 163) with videos related to
Page
of 17
Sort By:
Neuroinformatics
|
March 27, 2004
Informatics center for mouse genomics: the dissection of complex traits of the nervous system
Glenn D Rosen, Nathan T La Porte, Boris Diechtiareff, et al.
The Journal of Biological Chemistry
|
April 25, 2007
Nicotinic acid receptor agonists differentially activate downstream effectors
Jeremy G Richman, Martha Kanemitsu-Parks, Ibragim Gaidarov, et al.
Journal of Medicinal Chemistry
|
December 2, 2000
Discovery of chiral N,N-disubstituted trifluoro-3-amino-2-propanols as potent inhibitors of cholesteryl ester transfer protein
R C Durley, M L Grapperhaus, M A Massa, et al.
Nature Communications
|
July 2, 2022
Green gentrification in European and North American cities
Isabelle Anguelovski, James J T Connolly, Helen Cole, et al.
Journal of Medicinal Chemistry
|
May 16, 2003
Discovery of a simple picomolar inhibitor of cholesteryl ester transfer protein
Emily J Reinhard, Jane L Wang, Richard C Durley, et al.
Journal of Medicinal Chemistry
|
May 12, 2010
Discovery and structure-activity relationship of 3-methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): a highly selective 5-hydroxytryptamine2A receptor inverse agonist for the treatment of arterial thrombosis
Yifeng Xiong, Bradley R Teegarden, Jin-Sun Karoline Choi, et al.
Journal of Medicinal Chemistry
|
August 23, 2002
Chiral N,N-disubstituted trifluoro-3-amino-2-propanols are potent inhibitors of cholesteryl ester transfer protein
Richard C Durley, Margaret L Grapperhaus, Brian S Hickory, et al.
Journal of Medicinal Chemistry
|
July 31, 2008
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice
Graeme Semple, Philip J Skinner, Tawfik Gharbaoui, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 26, 2007
Agonist lead identification for the high affinity niacin receptor GPR109a
Tawfik Gharbaoui, Philip J Skinner, Young-Jun Shin, et al.
Journal of Medicinal Chemistry
|
March 23, 2012
(1aR,5aR)1a,3,5,5a-Tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalene-4-carboxylic acid (MK-1903): a potent GPR109a agonist that lowers free fatty acids in humans
P Douglas Boatman, Brett Lauring, Thomas O Schrader, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 163) with videos related to
Sort By:
Page
of 17
Neuroinformatics
|
March 27, 2004
Informatics center for mouse genomics: the dissection of complex traits of the nervous system
Glenn D Rosen, Nathan T La Porte, Boris Diechtiareff, et al.
The Journal of Biological Chemistry
|
April 25, 2007
Nicotinic acid receptor agonists differentially activate downstream effectors
Jeremy G Richman, Martha Kanemitsu-Parks, Ibragim Gaidarov, et al.
Journal of Medicinal Chemistry
|
December 2, 2000
Discovery of chiral N,N-disubstituted trifluoro-3-amino-2-propanols as potent inhibitors of cholesteryl ester transfer protein
R C Durley, M L Grapperhaus, M A Massa, et al.
Nature Communications
|
July 2, 2022
Green gentrification in European and North American cities
Isabelle Anguelovski, James J T Connolly, Helen Cole, et al.
Journal of Medicinal Chemistry
|
May 16, 2003
Discovery of a simple picomolar inhibitor of cholesteryl ester transfer protein
Emily J Reinhard, Jane L Wang, Richard C Durley, et al.
Journal of Medicinal Chemistry
|
May 12, 2010
Discovery and structure-activity relationship of 3-methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): a highly selective 5-hydroxytryptamine2A receptor inverse agonist for the treatment of arterial thrombosis
Yifeng Xiong, Bradley R Teegarden, Jin-Sun Karoline Choi, et al.
Journal of Medicinal Chemistry
|
August 23, 2002
Chiral N,N-disubstituted trifluoro-3-amino-2-propanols are potent inhibitors of cholesteryl ester transfer protein
Richard C Durley, Margaret L Grapperhaus, Brian S Hickory, et al.
Journal of Medicinal Chemistry
|
July 31, 2008
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice
Graeme Semple, Philip J Skinner, Tawfik Gharbaoui, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 26, 2007
Agonist lead identification for the high affinity niacin receptor GPR109a
Tawfik Gharbaoui, Philip J Skinner, Young-Jun Shin, et al.
Journal of Medicinal Chemistry
|
March 23, 2012
(1aR,5aR)1a,3,5,5a-Tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalene-4-carboxylic acid (MK-1903): a potent GPR109a agonist that lowers free fatty acids in humans
P Douglas Boatman, Brett Lauring, Thomas O Schrader, et al.
Page
of 17